<DOC>
	<DOC>NCT03106623</DOC>
	<brief_summary>The objective of the study is to evaluate the efficacy and safety of ONO-8577 compared to combination of solifenacin succinate and mirabegron or placebo for overactive bladder</brief_summary>
	<brief_title>Study of ONO-8577 in Patients With Overactive Bladder</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder, Overactive</mesh_term>
	<mesh_term>Solifenacin Succinate</mesh_term>
	<mesh_term>Mirabegron</mesh_term>
	<criteria>Patient with symptoms of overactive bladder for â‰¥6 months Patient with genuine stress incontinence, or with stresspredominant mixed urinary incontinence Patient who has never experienced urge urinary incontinence during disease duration of overactive bladder</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>